/PNV
PNV
Updated 7 Sept 08:16 am
$1.04
POLYNOVO LIMITED
1D-1.93%
1M-2.09%
1Y-26.67%
Track your position in PNV
Sign in to TradeLedgr to record trades in PNV (POLYNOVO LIMITED) with broker-true precision and ATO-compliant reporting.
Recent Announcements
26 Aug 2026 5:58 AM
PolyNovo FY26 Results Presentation Webinar Recording157KB
Web Cast
25 Aug 2026 9:56 PM
FY26 Full Year Results Investor Presentation13889KB
Company Presentation
25 Aug 2026 9:56 PM
ASX Announcement - FY26 Full Year Results189KB
Web Cast
25 Aug 2026 9:55 PM
FY26 Full Year Results and Appendix 4E3698KB
Annual Report
23 Aug 2026 10:00 PM
Ceasing to be a substantial holder927KB
Ceasing to be a substantial holder
Fundamentals
P/E Ratio
96.99x
Div Yield
0.00%
EPS
$0.0106
Avg Vol
2.8M
52W High
$1.660
52W Low
$0.810
Company Profile
PolyNovo develops and commercialises innovative medical devices using its NovoSorb technology in the treatment of burns, surgical wounds and Negative Pressure Wound Therapy.
Financial History
2026A
$7.3M profit
$143.8M rev
2025A
$13.2M profit
$127.7M rev
2024A
$5.3M profit
$104.7M rev